Autoantibodies to Annexin A2 and cerebral thrombosis: Insights from a mouse model.

CONCLUSIONS: This study supports the hypothesis that auto-antibodies to ANXA2 are an independent risk factor for cerebral thrombosis. Consequently, we propose screening for anti-ANXA2 antibodies should be more widely used and patients that exhibit the manifestations of APS should be closely monitored by physicians.
PMID: 33554716 [PubMed - as supplied by publisher]

Source: Lupus - February 7, 2021 Category: Rheumatology Authors: Weiss R, Bushi D, Mindel E, Bitton A, Diesendruck Y, Gera O, Drori T, Zmira O, Aharoni SA, Agmon-Levin N, Kashi O, Benhar I, Golderman V, Orion D, Chapman J, Shavit-Stein E Tags: Lupus Source Type: research